Vascular Endothelial Growth Factor A Isoform mRNA Expression in Pediatric Acute Myeloid Leukemia

被引:8
|
作者
Kruizinga, R. C. [1 ,2 ]
de Jonge, H. J. M. [1 ]
Kampen, K. R. [1 ]
Walenkamp, A. M. E. [2 ]
de Bont, E. S. J. M. [1 ]
机构
[1] Univ Groningen, Div Pediat Oncol Hematol, Dept Pediat,Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Med Oncol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
关键词
AML; isoform; VEGFA; SPLICE VARIANTS; VEGF-A; AML; 10; SURVIVAL; ANGIOGENESIS; TUMORS;
D O I
10.1002/pbc.22783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In AML high VEGFA protein expression correlates with poor overall and relapse-free survival (OS/RFS). To date, the relevance of the various VEGFA isoforms is unclear. We determined VEGF121, VEGF145, VEGF148, VEGF165, VEGF183, and VEGF189 mRNA expression in pediatric AML samples and investigated the relation between VEGFA isoform expression and clinicopatholologic characteristics and outcome. A significant co-expression of VEGF121, VEGF165, VEGF183, and VEGF189 isoforms was apparent (mean rho = 0.716, P<0.0001). This co-expression justifies measuring a single VEGFA isoform (e.g., 121, 165, 183, and 189) as representative expression of all VEGFA isoforms in future studies designed to determine the prognostic importance of VEGFA isoforms. Pediatr Blood Cancer 2011;56:294-297. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:294 / 297
页数:4
相关论文
共 50 条
  • [41] Bone marrow expression of vascular endothelial growth factor in myelofibrosis with myeloid metaplasia
    Ho, CL
    Arora, B
    Hoyer, JD
    Wellik, LE
    Mesa, RA
    Tefferi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (01) : 35 - 39
  • [42] Vascular endothelial growth factor mRNA and protein expression in the developing human eye
    Ma, I. T.
    Rowe, M. J.
    Patel, S.
    Padilla, M.
    Ohls, R. K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 168 - 169
  • [43] Regulation of vascular endothelial growth factor mRNA expression in human keratinocytes by retinoids
    Vega-Diaz, B
    Ladoux, A
    Frelin, C
    Démarchez, M
    Michel, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 609 - 609
  • [44] Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis
    Song, Mingzhu
    Wang, Huiping
    Ye, Qianling
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [45] Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis
    Mingzhu Song
    Huiping Wang
    Qianling Ye
    Systematic Reviews, 9
  • [46] Wtl mRNA expression as a significant prognostic factor for outcome in patients with acute myeloid leukemia
    Miething, CC
    Weidmann, E
    Maurer, U
    Hoelzer, D
    Bergmann, L
    BLOOD, 1996, 88 (10) : 2243 - 2243
  • [47] Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes
    Hu, QL
    Dey, AL
    Yang, Y
    Shen, Y
    Jilani, IB
    Estey, EH
    Kantarjian, HM
    Giles, FJ
    Albitar, M
    CANCER, 2004, 100 (09) : 1884 - 1891
  • [48] Value of microvessel density(MVD) and vascular endothelial growth factor (VEGF) expression in adult acute myeloid (AML) leukemia before and after therapy.
    Kuzu, I
    Beksac, M
    Çelebi, H
    Arat, M
    Erekul, S
    BLOOD, 1999, 94 (10) : 207B - 207B
  • [49] Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas
    Sakuma, Takahiro
    Nakagawa, Takao
    Ido, Kazunori
    Takeuchi, Hiroaki
    Sato, Kazufumi
    Kubota, Toshihiko
    JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (02) : 143 - 155
  • [50] Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas
    Takahiro Sakuma
    Takao Nakagawa
    Kazunori Ido
    Hiroaki Takeuchi
    Kazufumi Sato
    Toshihiko Kubota
    Journal of Neuro-Oncology, 2008, 88 : 143 - 155